{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,7]],"date-time":"2026-02-07T23:20:35Z","timestamp":1770506435421,"version":"3.49.0"},"reference-count":60,"publisher":"Wiley","issue":"4","license":[{"start":{"date-parts":[[2006,7,14]],"date-time":"2006-07-14T00:00:00Z","timestamp":1152835200000},"content-version":"vor","delay-in-days":4608,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Genes Chromosomes &amp; Cancer"],"published-print":{"date-parts":[[1993,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Research in oncogenetics has led to the identification of two major classes of tumor\u2010associated genes, oncogenes and tumor suppressor genes. In a wide variety of solid tumor types, mutations of both groups of genes have been implicated in the tumorigenic process. In hematologic neoplasms, on the other hand, most attention has focused on illegitimate activation of oncogenes, e.g., deregulation leading to disturbed transcriptional activity and structural rearrangements resulting in hybrid genes. Whether loss or mutational inactivation of tumor suppressor genes also plays an essential role in the genesis of tumors of the hematopoietic system has received less attention. Because such inactivation can be the result of karyotypically detectable loss of chromosomal material, cytogenetic studies may prove helpful in pinpointing genomic sites that harbor tumor suppressor genes. The present study is based on a total of 12,473 cytogenetically abnormal hematologic neoplasms reported in the literature to date. Among these, we selected the 6,422 cases with sole clonal chromosomal abnormalities in order to include only aberrations of importance in the genesis, rather than in the progression, of these neoplasms. All tumors with monosomies or structural abnormalities resulting in loss of chromosomal material were compiled, and for every such structural aberration, i.e., deletion, unbalanced translocation, isochromosome, and ring chromosome, the chromosome bands lost were ascertained. This cytogenetic deletion mapping revealed that the most commonly lost chromosomes were Y and 7 in acute myeloid leukemia (AML), myelodysplastic syndromes (MDS), and chronic myeloproliferative disorders (MPD); X, Y, 7, 20, and 21 in acute lymphocytic leukemia (ALL); X, Y, and 17 in chronic lymphoproliferative disorders (LPD); and X and Y in non\u2010Hodgkin's lymphoma (NHL). Chromosome segments\/bands lost due to unbalanced structural abnormalities in at least 5% of the cases were 5q13ndash;33. 7q22ndash;36, 9q13ndash;31, 11q23ndash;25, 12p12ndash;13, 17p11ndash;13, and 20q11ndash;13 in AML; 5q13ndash;35 and 20q11ndash;13 in MDS; 5q22ndash;23, 7q22, 13q12ndash;22, 17p11ndash;13, and 20q11ndash;13 in MPD; 6q15ndash;27, 9p11ndash;24, 12p12ndash;13, and 19p13 in ALL; 6q16ndash;27, 11q21ndash;25, 13q13ndash;14, and 14q32 in LPD; and 6q21ndash;27, 11q13ndash;25, and 14q24ndash;32 in NHL. Based on these findings, three conclusions can be drawn. First, there is no good correspondence between total and partial monosomies, the only exception being ndash;7 and 7qndash;, both of which are common in myeloid neoplasms. This indicates different pathogenetic effects of total and partial losses. Second, clinically and biologically related hematologic malignancies display similarities in chromosomal material lost. Third, molecular studies on genetic loss have, to date, focused on deletions involving the long arms of chromosomes 5, 6, 7, 13, and 20 and the short arms of chromosomes 9 and 17. The cytogenetic deletion maps presented herein indicate that there are also other genomic sites of interest for further molecular analyses. \u00a9 1993 Wiley\u2010Liss, Inc.<\/jats:p>","DOI":"10.1002\/gcc.2870080402","type":"journal-article","created":{"date-parts":[[2007,2,21]],"date-time":"2007-02-21T23:51:58Z","timestamp":1172101918000},"page":"205-218","source":"Crossref","is-referenced-by-count":122,"title":["Cytogenetic deletion maps of hematologic neoplasms: Circumstantial evidence for tumor suppressor Loci"],"prefix":"10.1002","volume":"8","author":[{"given":"Bertil","family":"Johansson","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fredrik","family":"Mertens","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Felix","family":"Mitelman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2006,7,14]]},"reference":[{"key":"e_1_2_1_2_1","doi-asserted-by":"publisher","DOI":"10.1002\/ajh.2830420206"},{"key":"e_1_2_1_3_1","doi-asserted-by":"publisher","DOI":"10.1038\/318533a0"},{"key":"e_1_2_1_4_1","doi-asserted-by":"publisher","DOI":"10.1126\/science.2144057"},{"key":"e_1_2_1_5_1","doi-asserted-by":"publisher","DOI":"10.1126\/science.3469751"},{"key":"e_1_2_1_6_1","first-page":"146","article-title":"Deletion of c\u2010fms sequences in the 5q syndrome","volume":"1","author":"Bartram CR","year":"1987","journal-title":"Leukemia"},{"key":"e_1_2_1_7_1","doi-asserted-by":"publisher","DOI":"10.1126\/science.3541204"},{"key":"e_1_2_1_8_1","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.88.14.6176"},{"key":"e_1_2_1_9_1","doi-asserted-by":"publisher","DOI":"10.1038\/ng0193-67"},{"key":"e_1_2_1_10_1","doi-asserted-by":"publisher","DOI":"10.1002\/gcc.2870040102"},{"key":"e_1_2_1_11_1","doi-asserted-by":"crossref","first-page":"2060","DOI":"10.1182\/blood.V76.10.2060.2060","article-title":"Deletion of the human retinoblastoma gene in primary leukemias","volume":"76","author":"Chen Y\u2010C","year":"1990","journal-title":"Blood"},{"key":"e_1_2_1_12_1","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1182\/blood.V75.3.730.730","article-title":"Homozygous deletion of the retinoblastoma gene in an acute lymphoblastic leukemia (T) cell line","volume":"75","author":"Cheng J","year":"1990","journal-title":"Blood"},{"key":"e_1_2_1_13_1","doi-asserted-by":"publisher","DOI":"10.1002\/gcc.2870060207"},{"key":"e_1_2_1_14_1","doi-asserted-by":"publisher","DOI":"10.1016\/0092-8674(91)90105-8"},{"key":"e_1_2_1_15_1","doi-asserted-by":"publisher","DOI":"10.1126\/science.2406902"},{"key":"e_1_2_1_16_1","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.85.14.5259"},{"key":"e_1_2_1_17_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199001113220202"},{"key":"e_1_2_1_18_1","doi-asserted-by":"publisher","DOI":"10.1126\/science.1656527"},{"key":"e_1_2_1_19_1","first-page":"7781","article-title":"Deletion of \u03b1\u2010, \u03b2\u2010, and \u03c9\u2010interferon genes in malignant cells from children with acute lymphocytic leukemia","volume":"50","author":"Einhorn S","year":"1990","journal-title":"Cancer Res"},{"key":"e_1_2_1_20_1","doi-asserted-by":"publisher","DOI":"10.1016\/0092-8674(91)90038-Z"},{"key":"e_1_2_1_21_1","doi-asserted-by":"publisher","DOI":"10.1016\/0092-8674(90)90186-I"},{"key":"e_1_2_1_22_1","doi-asserted-by":"publisher","DOI":"10.1016\/0165-4608(90)90159-8"},{"key":"e_1_2_1_23_1","first-page":"37","article-title":"Cytogenetics of solid tumours","volume":"15","author":"Heim S","year":"1992","journal-title":"Rec Adv Histopathol"},{"key":"e_1_2_1_24_1","doi-asserted-by":"publisher","DOI":"10.1016\/0165-4608(92)90109-L"},{"key":"e_1_2_1_25_1","doi-asserted-by":"publisher","DOI":"10.1126\/science.2999978"},{"key":"e_1_2_1_26_1","first-page":"4071","article-title":"Lineage\u2010specific gene rearrangement\/deletion: A nonconservative model","volume":"49","author":"Huebner K","year":"1989","journal-title":"Cancer Res"},{"key":"e_1_2_1_27_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM198702263160902"},{"key":"e_1_2_1_28_1","doi-asserted-by":"crossref","first-page":"1349","DOI":"10.1182\/blood.V70.5.1349.1349","article-title":"Molecular characterization of chromosome 7 long arm deletions in myeloid disorders","volume":"70","author":"Kere J","year":"1987","journal-title":"Blood"},{"key":"e_1_2_1_29_1","doi-asserted-by":"publisher","DOI":"10.1159\/000132765"},{"key":"e_1_2_1_30_1","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1182\/blood.V73.1.230.230","article-title":"Chromosome 7 long arm deletion in myeloid disorders: A narrow breakpoint region in 7q22 defined by molecular mapping","volume":"73","author":"Kere J","year":"1989","journal-title":"Blood"},{"key":"e_1_2_1_31_1","doi-asserted-by":"publisher","DOI":"10.1038\/315190a0"},{"key":"e_1_2_1_32_1","first-page":"1437","article-title":"Hereditary cancer, oncogenes, and antioncogenes","volume":"45","author":"Knudson AG","year":"1985","journal-title":"Cancer Res"},{"key":"e_1_2_1_33_1","doi-asserted-by":"crossref","unstructured":"KobayashiH EspinosaRIII ThirmanMJ FernaldAA ShannonK DiazMO Le BeauMM RowleyJD(1993) Do terminal deletions of 11q23 exist? Identification of undetected translocations with fluorescence in situ hybridization.Genes Chrom Cancer(in press).","DOI":"10.1002\/gcc.2870070404"},{"key":"e_1_2_1_34_1","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.82.19.6692"},{"key":"e_1_2_1_35_1","doi-asserted-by":"publisher","DOI":"10.1126\/science.3484837"},{"key":"e_1_2_1_36_1","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.84.16.5913"},{"key":"e_1_2_1_37_1","first-page":"53","article-title":"Molecular and cytogenetic analysis of chromosome 5 abnormalities in myeloid disorders: Chromosomal localization and physical mapping of IL\u20104 and IL\u20105","volume":"7","author":"Le Beau MM","year":"1989","journal-title":"Cancer Cells"},{"key":"e_1_2_1_38_1","doi-asserted-by":"publisher","DOI":"10.1002\/gcc.2870040310"},{"key":"e_1_2_1_39_1","first-page":"2056","volume-title":"Catalog of Chromosome Aberrations in Cancer","author":"Mitelman F","year":"1991"},{"key":"e_1_2_1_40_1","doi-asserted-by":"crossref","first-page":"1768","DOI":"10.1182\/blood.V74.5.1768.1768","article-title":"Localization of the SRC oncogene to chromosome band 20q11.2 and loss of this gene with deletion (20q) in two leukemic patients","volume":"74","author":"Morris CM","year":"1989","journal-title":"Blood"},{"key":"e_1_2_1_41_1","doi-asserted-by":"publisher","DOI":"10.1159\/000132929"},{"key":"e_1_2_1_42_1","doi-asserted-by":"publisher","DOI":"10.1002\/gcc.2870030607"},{"key":"e_1_2_1_43_1","doi-asserted-by":"crossref","first-page":"1501","DOI":"10.1182\/blood.V79.6.1501.1501","article-title":"Chromosomal loss and deletion are the most common mechanisms for loss of heterozygosity from chromosomes 5 and 7 in malignant myeloid disorders","volume":"79","author":"Neuman WL","year":"1992","journal-title":"Blood"},{"key":"e_1_2_1_44_1","doi-asserted-by":"publisher","DOI":"10.1016\/0092-8674(85)90099-6"},{"key":"e_1_2_1_45_1","first-page":"116","article-title":"Chromosomal and molecular clues to tumor progression","volume":"16","author":"Nowell PC","year":"1989","journal-title":"Semin Oncol"},{"key":"e_1_2_1_46_1","doi-asserted-by":"publisher","DOI":"10.1016\/0165-4608(88)90053-2"},{"key":"e_1_2_1_47_1","doi-asserted-by":"publisher","DOI":"10.1016\/0165-4608(90)90125-T"},{"key":"e_1_2_1_48_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0888-7543(05)80238-1"},{"key":"e_1_2_1_49_1","doi-asserted-by":"publisher","DOI":"10.1016\/0092-8674(91)90057-6"},{"key":"e_1_2_1_50_1","doi-asserted-by":"publisher","DOI":"10.1016\/0888-7543(92)90190-4"},{"key":"e_1_2_1_51_1","doi-asserted-by":"publisher","DOI":"10.1016\/0145-2126(91)90004-D"},{"key":"e_1_2_1_52_1","first-page":"5","article-title":"Functional evidence for human tumour suppressor genes: Chromosome and molecular genetic studies","volume":"12","author":"Stanbridge EJ","year":"1992","journal-title":"Cancer Surveys"},{"key":"e_1_2_1_53_1","doi-asserted-by":"publisher","DOI":"10.1093\/oxfordjournals.aje.a116271"},{"key":"e_1_2_1_54_1","doi-asserted-by":"crossref","first-page":"1150","DOI":"10.1182\/blood.V71.4.1150.1150","article-title":"Interleukin\u20105 is at 5q31 and is deleted in the 5q syndrome","volume":"71","author":"Sutherland GR","year":"1988","journal-title":"Blood"},{"key":"e_1_2_1_55_1","doi-asserted-by":"publisher","DOI":"10.1038\/349340a0"},{"key":"e_1_2_1_56_1","doi-asserted-by":"publisher","DOI":"10.1006\/geno.1993.1032"},{"key":"e_1_2_1_57_1","doi-asserted-by":"publisher","DOI":"10.1126\/science.3554512"},{"key":"e_1_2_1_58_1","doi-asserted-by":"publisher","DOI":"10.1126\/science.2300817"},{"key":"e_1_2_1_59_1","first-page":"1355","article-title":"Assessment of clonality in human tumors: A review","volume":"50","author":"Wainscoat JS","year":"1990","journal-title":"Cancer Res"},{"key":"e_1_2_1_60_1","first-page":"3713","article-title":"Oncogenes, antioncogenes, and the molecular bases of multistep carcinogenesis","volume":"49","author":"Weinberg RA","year":"1989","journal-title":"Cancer Res"},{"key":"e_1_2_1_61_1","doi-asserted-by":"publisher","DOI":"10.1126\/science.8438156"}],"container-title":["Genes, Chromosomes and Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fgcc.2870080402","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/gcc.2870080402","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,25]],"date-time":"2023-10-25T23:42:57Z","timestamp":1698277377000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1002\/gcc.2870080402"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1993,12]]},"references-count":60,"journal-issue":{"issue":"4","published-print":{"date-parts":[[1993,12]]}},"alternative-id":["10.1002\/gcc.2870080402"],"URL":"https:\/\/doi.org\/10.1002\/gcc.2870080402","archive":["Portico"],"relation":{},"ISSN":["1045-2257","1098-2264"],"issn-type":[{"value":"1045-2257","type":"print"},{"value":"1098-2264","type":"electronic"}],"subject":[],"published":{"date-parts":[[1993,12]]}}}